Ambee Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 2/6
Ambee Pharmaceuticals has a total shareholder equity of BDT22.6M and total debt of BDT424.2M, which brings its debt-to-equity ratio to 1874%. Its total assets and total liabilities are BDT535.9M and BDT513.3M respectively. Ambee Pharmaceuticals's EBIT is BDT12.7M making its interest coverage ratio 8.9. It has cash and short-term investments of BDT39.5M.
Key information
1,874.0%
Debt to equity ratio
৳424.24m
Debt
Interest coverage ratio | 8.9x |
Cash | ৳39.47m |
Equity | ৳22.64m |
Total liabilities | ৳513.26m |
Total assets | ৳535.90m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMBEEPHA's short term assets (BDT451.2M) do not cover its short term liabilities (BDT507.6M).
Long Term Liabilities: AMBEEPHA's short term assets (BDT451.2M) exceed its long term liabilities (BDT5.6M).
Debt to Equity History and Analysis
Debt Level: AMBEEPHA's net debt to equity ratio (1699.6%) is considered high.
Reducing Debt: AMBEEPHA's debt to equity ratio has increased from 192.4% to 1874% over the past 5 years.
Debt Coverage: AMBEEPHA's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: AMBEEPHA's interest payments on its debt are well covered by EBIT (8.9x coverage).